Which has grown faster, TXG or UHS?

Over the past five years, TXG grew revenue faster — TXG at a 8.74% CAGR versus UHS at 8.21%.

Does TXG or UHS pay a bigger dividend?

UHS pays a dividend (0.45% yield), while TXG has no payments in the available dividend history.

Is TXG or UHS more profitable?

UHS runs the higher net margin — TXG at -12.18% versus UHS at 8.42%.

How have TXG and UHS total returns compared?

Over the past 5 years, TXG delivered -7.24% and UHS delivered 6.18% annualized total return. Past performance doesn't predict future results.

10x Genomics, Inc. (TXG) vs Universal Health Services, Inc. (UHS)

A side-by-side comparison of 10x Genomics, Inc. and Universal Health Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

TXG

10x Genomics, Inc.

$10.24B

$80.66HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

UHS

Universal Health Services, Inc.

$10.72B

$177.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — TXG vs UHS

growth of $100 · dividends reinvested · last 7y

TXG +85.3% (+9.2%/yr)UHS +24.4% (+3.2%/yr)TXG compounded faster over this window

TXG UHS

TXG vs UHS: by the numbers

•UHS is the larger company ($10.72B vs $10.24B market cap).
•UHS is profitable (8.42% net margin) while TXG runs a net loss (-12.18%).
•TXG grew revenue faster over the past five years (8.74% vs 8.21% CAGR).
•UHS pays a dividend (0.45% yield), while TXG has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	TXG	UHS
P/E ratio	N/A	7.26
Forward P/E	N/A	7.84
PEG ratio	N/A	0.45
P/S ratio	16.60	0.59
P/B ratio	12.40	1.43
EV / EBITDA	N/A	5.87
FCF yield	1.19%	7.71%

Profitability

Metric	TXG	UHS
Gross margin	70.03%	90.69%
Operating margin	-14.33%	11.36%
Net margin	-12.18%	8.42%
ROE	-9.10%	20.31%
ROIC	-9.57%	11.74%

Dividends

Metric	TXG	UHS
Dividend yield	N/A	0.45%
Payout ratio	N/A	3.28%

Growth (annualized)

Metric	TXG	UHS
Revenue CAGR (5Y)	8.74%	8.21%
EPS CAGR (5Y)	N/A	16.19%
FCF CAGR (5Y)	N/A	-12.18%
Total return CAGR (5Y)	-7.24%	6.18%

Frequently asked

Which has grown faster, TXG or UHS?: Over the past five years, TXG grew revenue faster — TXG at a 8.74% CAGR versus UHS at 8.21%.
Does TXG or UHS pay a bigger dividend?: UHS pays a dividend (0.45% yield), while TXG has no payments in the available dividend history.
Is TXG or UHS more profitable?: UHS runs the higher net margin — TXG at -12.18% versus UHS at 8.42%.
How have TXG and UHS total returns compared?: Over the past 5 years, TXG delivered -7.24% and UHS delivered 6.18% annualized total return. Past performance doesn't predict future results.

Go deeper

Full TXG analysis Full UHS analysis Interactive comparison tool

Dig into the metrics

Universal Health Services P/E ratio Universal Health Services dividend yield 10x Genomics ROE Universal Health Services ROE 10x Genomics operating margin Universal Health Services operating margin 10x Genomics revenue growth Universal Health Services revenue growth 10x Genomics free cash flow Universal Health Services free cash flow

10x Genomics & Universal Health Services appear in these rankings

Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.